Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-11 4:43 pm Purchase |
2022-09-02 | 13G | ABIVAX SA ABVX |
Invus Public Equities, L.P. | 5,403,985 8.500% |
5,403,985 (New Position) |
Filing History |
| 2025-02-14 4:19 pm Purchase |
2025-02-14 | 13D | ABIVAX SA ABVX |
Sofinnova Crossover I SLP | 7,794,478 11.000% |
845,865 (+12.17%) |
Filing History |
| 2024-11-14 09:09 am Sale |
2024-09-30 | 13G | ABIVAX SA ABVX |
Deep Track Capital, LP | 3,579,209 5.080% |
-718,229 (-16.71%) |
Filing History |
| 2024-04-19 7:09 pm Purchase |
2024-04-11 | 13G | ABIVAX SA ABVX |
TCG Crossover GP I, LLC | 6,056,596 9.600% |
6,056,596 (New Position) |
Filing History |
| 2024-02-14 8:25 pm Purchase |
2023-12-31 | 13G | ABIVAX SA ABVX |
Venrock Healthcare Capital Partners III L.P. | 3,611,570 5.700% |
298,570 (+9.01%) |
Filing History |
| 2023-11-22 4:16 pm Purchase |
2023-10-24 | 13G | ABIVAX SA ABVX |
Venrock Healthcare Capital Partners III L.P. | 3,313,000 5.300% |
3,313,000 (New Position) |
Filing History |
| 2023-10-30 4:13 pm Purchase |
2023-10-20 | 13G | ABIVAX SA ABVX |
Deep Track Capital, LP | 4,297,438 6.140% |
4,297,438 (New Position) |
Filing History |
| 2023-10-30 1:42 pm Purchase |
2023-10-20 | 13D | ABIVAX SA ABVX |
Sofinnova Crossover I SLP | 6,948,613 8.000% |
6,948,613 (New Position) |
Filing History |